Thomas DiRaimondo
Directeur Technique/Scientifique/R&D chez JANUX THERAPEUTICS, INC.
Fortune : 5 M $ au 30/04/2024
Postes actifs de Thomas DiRaimondo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| JANUX THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/05/2018 | - |
Historique de carrière de Thomas DiRaimondo
Anciens postes connus de Thomas DiRaimondo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Sitari Pharma, Inc.
 Sitari Pharma, Inc. BiotechnologyHealth Technology Sitari Pharma, Inc. provides pharmaceutical research and development services. It engages in multiple disease indications such as celiac disease. The company was founded by Chaitan S. Khosla and Thomas DiRaimondo in 2013 and is headquartered in La Jolla, CA. | Fondateur | 01/01/2013 | 01/08/2019 |
Formation de Thomas DiRaimondo
| Stanford University | Doctorate Degree |
| University of Michigan | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Founder | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JANUX THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Sitari Pharma, Inc.
Sitari Pharma, Inc. BiotechnologyHealth Technology Sitari Pharma, Inc. provides pharmaceutical research and development services. It engages in multiple disease indications such as celiac disease. The company was founded by Chaitan S. Khosla and Thomas DiRaimondo in 2013 and is headquartered in La Jolla, CA. | Health Technology |
- Bourse
- Insiders
- Thomas DiRaimondo
- Expérience